Latest NAV & returns of MAHINDRA ASSET MANAGEMENT CO PVT. LTD.

Mahindra Manulife Consumption Fund Direct Growth

Add To Compare

previously known as Mahindra Manu Rural Bharat&Consmp Dir Gr until

NAV on December 12, 2025
Category Equity:
Equity - Consumption
Investment StyleBox
Large Growth
Total Assets 565 cr
Turnover Ratio 26.85%
Expense Ratio 0.63%
Exit Load 1.00%if redeemed within
3 Months
0.00%if redeemed after 3 Months
Returns
  • 1M: -1.27%
  • 1Y: 0.61%
  • 3M: -1.84%
  • 3Y: 16.50%
  • 6M: 5.10%
  • 5Y: 17.92%
Min Investment 1,000
ADDITIONAL INFO
Fund Manager Fatema Pacha (Since almost 5 years) Navin Matta (Since about 1 year)
ISIN INF174V01663
Fund Family Mahindra
P/E Ratio 36.95
P/B Ratio 6.36
Launch Date November 16, 2018
Benchmark Nifty India Consumption TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty India Consumption TR INR

Alpha 0.30
Beta 0.90
R-Squared 91.28
Info Ratio -0.17
Tracking Err 4.22
Sortino 1.107
Sharpe 0.738
Std Dev 13.558
Risk Average
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 7.99%
Technology 1.36%
Basic Materials 2.83%
Consumer Cyclical 42.09%
Utilities Services 1.89%
Healthcare Services 1.78%
Energy Services 0.00%
Communication Services 12.17%
Consumer Defensive 28.26%
Real Estate 1.65%
INVESTMENT OBJECTIVE

The investment objective of the Scheme is to generate long term capital appreciation by investing in a portfolio of companies that are likely to benefit from consumption led demand in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

Top Equity Consumption Funds
NAME LATEST
NAV
RETURNS
1y      
FUND
ASSETS
EXPENSE
RATIO
RISK
113.153 2.59% 4,787 cr 0.41% High
128.860 2.56% 2,036 cr 0.79% Low
Best Equity Consumption Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
113.153 2.59% 4,787 cr 0.41% High
35.728 0.92% 1,553 cr 0.64% Below Average
52.193 -1.58% 2,685 cr 0.69% Average


Other plans of Mahindra Manulife Consumption Fund


Other Equity funds by Mahindra